84 related articles for article (PubMed ID: 9781341)
1. Structural and immunochemical studies on bovine lactoferrin fragments.
Shimazaki K; Kamio M; Nam MS; Harakawa S; Tanaka T; Omata Y; Saito A; Kumura H; Mikawa K; Igarashi I; Suzuki N
Adv Exp Med Biol; 1998; 443():41-8. PubMed ID: 9781341
[No Abstract] [Full Text] [Related]
2. Monoclonal antibody against bovine Lactoferricin and its epitopic site.
Shimazaki K; Nam MS; Harakawa S; Tanaka T; Omata Y; Saito A; Kumura H; Mikawa K; Igarashi I; Suzuki N
J Vet Med Sci; 1996 Dec; 58(12):1227-9. PubMed ID: 8996707
[TBL] [Abstract][Full Text] [Related]
3. Characterization of monoclonal antibodies against human lactoferrin.
van Berkel PH; van Veen HA; Geerts ME; Nuijens JH
J Immunol Methods; 2002 Sep; 267(2):139-50. PubMed ID: 12165435
[TBL] [Abstract][Full Text] [Related]
4. Non-reducing terminal fucose within N-linked glycan plays a significant role in the recognition of human milk lactoferrin by the 1CF11 monoclonal antibody.
Fukaya S; Yabe T; Kanamaru Y
Biosci Biotechnol Biochem; 2010; 74(10):2141-4. PubMed ID: 20944405
[TBL] [Abstract][Full Text] [Related]
5. Lactoferrampin: a novel antimicrobial peptide in the N1-domain of bovine lactoferrin.
van der Kraan MI; Groenink J; Nazmi K; Veerman EC; Bolscher JG; Nieuw Amerongen AV
Peptides; 2004 Feb; 25(2):177-83. PubMed ID: 15062998
[TBL] [Abstract][Full Text] [Related]
6. Tyrosine- versus serine-phosphorylation leads to conformational changes in a synthetic tau peptide.
Fabian H; Otvos L; Szendrei GI; Lang E; Mantsch HH
J Biomol Struct Dyn; 1994 Dec; 12(3):573-9. PubMed ID: 7537044
[TBL] [Abstract][Full Text] [Related]
7. Identification of the bactericidal domain of lactoferrin.
Bellamy W; Takase M; Yamauchi K; Wakabayashi H; Kawase K; Tomita M
Biochim Biophys Acta; 1992 May; 1121(1-2):130-6. PubMed ID: 1599934
[TBL] [Abstract][Full Text] [Related]
8. Properties of a heparin-binding peptide derived from bovine lactoferrin.
Shimazaki K; Tazume T; Uji K; Tanaka M; Kumura H; Mikawa K; Shimo-Oka T
J Dairy Sci; 1998 Nov; 81(11):2841-9. PubMed ID: 9839225
[TBL] [Abstract][Full Text] [Related]
9. A peptide domain of bovine milk lactoferrin inhibits the interaction between streptococcal surface protein antigen and a salivary agglutinin peptide domain.
Oho T; Bikker FJ; Nieuw Amerongen AV; Groenink J
Infect Immun; 2004 Oct; 72(10):6181-4. PubMed ID: 15385529
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the protein and glycan moieties in different forms of bovine lactoferrin.
Ye XY; Nishimura T; Yoshida S
Biosci Biotechnol Biochem; 1997 May; 61(5):782-6. PubMed ID: 9178553
[TBL] [Abstract][Full Text] [Related]
11. Conformational requirements for molecular recognition of acetylcholine receptor main immunogenic region (MIR) analogues by monoclonal anti-MIR antibody: a two-dimensional nuclear magnetic resonance and molecular dynamics approach.
Tsikaris V; Detsikas E; Sakarellos-Daitsiotis M; Sakarellos C; Vatzaki E; Tzartos SJ; Marraud M; Cung MT
Biopolymers; 1993 Jul; 33(7):1123-34. PubMed ID: 8343589
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of iron/ascorbate-induced lipid peroxidation by an N-terminal peptide of bovine lactoferrin and its acylated derivatives.
Wakabayashi H; Matsumoto H; Hashimoto K; Teraguchi S; Takase M; Hayasawa H
Biosci Biotechnol Biochem; 1999 May; 63(5):955-7. PubMed ID: 10380640
[TBL] [Abstract][Full Text] [Related]
13. Unique epitopes of lactoferrin expressed in human cytotrophoblasts involved in immunologic reactions.
Thaler CJ; Labarrere CA; Hunt JS; McIntyre JA; Faulk WP
Am J Obstet Gynecol; 1999 Aug; 181(2):460-7. PubMed ID: 10454701
[TBL] [Abstract][Full Text] [Related]
14. Anti-complement effects of lactoferrin-derived peptides.
Samuelsen Ø; Haukland HH; Ulvatne H; Vorland LH
FEMS Immunol Med Microbiol; 2004 Jun; 41(2):141-8. PubMed ID: 15145458
[TBL] [Abstract][Full Text] [Related]
15. Immunogenic properties of an anti-DNA antibody-derived peptide, 88H.64-80: location of a dominant idiotope defined by T and B cells.
Ward FJ; Khan N; Wolger LJ; Howe CA; Eivazova ER; Harper N; Muller S; Staines NA
J Autoimmun; 1998 Oct; 11(5):439-47. PubMed ID: 9802927
[TBL] [Abstract][Full Text] [Related]
16. Effect of trypsin on bovine lactoferrin and interaction between the fragments under different conditions.
Mata L; Castillo H; Sánchez L; Puyol P; Calvo M
J Dairy Res; 1994 Aug; 61(3):427-32. PubMed ID: 7962841
[No Abstract] [Full Text] [Related]
17. Distinct bactericidal activities of bovine lactoferrin peptides LFampin 268-284 and LFampin 265-284: Asp-Leu-Ile makes a difference.
van der Kraan MI; Nazmi K; van 't Hof W; Amerongen AV; Veerman EC; Bolscher JG
Biochem Cell Biol; 2006 Jun; 84(3):358-62. PubMed ID: 16936807
[TBL] [Abstract][Full Text] [Related]
18. Involvement of both the N-glycan-relevant and N-glycan-irrelevant structural elements in the recognition of human milk lactoferrin by the 1CF11 monoclonal antibody.
Fukaya S; Shinoda C; Yabe T; Kanamaru Y
Biosci Biotechnol Biochem; 2010; 74(10):2127-9. PubMed ID: 20944410
[TBL] [Abstract][Full Text] [Related]
19. Direct detection and quantitative determination of bovine lactoferricin and lactoferrin fragments in human gastric contents by affinity mass spectrometry.
Kuwata H; Yip TT; Yip CL; Tomita M; Hutchens TW
Adv Exp Med Biol; 1998; 443():23-32. PubMed ID: 9781339
[TBL] [Abstract][Full Text] [Related]
20. Presence of a glycan at a potential N-glycosylation site, Asn-281, of bovine lactoferrin.
Wei Z; Nishimura T; Yoshida S
J Dairy Sci; 2000 Apr; 83(4):683-9. PubMed ID: 10791783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
